Brought to you by 
Collateral Therapeutics Inc. nets $13.2mm in IPO
13 Jul 1999
Executive Summary
Collateral Therapeutics (cardiovascular gene therapy products) raised net proceeds of $13.2mm in its initial public offering of 2.2mm common shares at $7.25 each, below its targeted price of $11-13.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Gene Therapy, Cell Therapy
- Large Molecule
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com